🔥🐔 BizChicken 🐔🔥
Companies Similar to Soleno Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Eledon Pharmaceuticals, Inc.
AT-1501
Eledon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing medicines for autoimmune diseases, amyotrophic lateral sclerosis (ALS), and organ or cell-based transplants. Its lead product candidate AT-1501 is in Phase 2 clinical trials.
Symbol: ELDN
Recent Price: $4.14
Industry: Biotechnology
CEO: Dr. David-Alexandre C. Gros M.D., Ph.D.
Sector: Healthcare
Employees: 20
Address: 19900 MacArthur Boulevard, Irvine, CA 92612
Phone: 949 238 8090
Last updated: 2024-12-31
Halozyme Therapeutics, Inc.
ENHANZE drug delivery technology
Halozyme Therapeutics, Inc. is a biopharma technology platform company specializing in enabling subcutaneous delivery of biologics using its patented ENHANZE technology. The company operates in the United States and internationally, offering products such as Hylenex recombinant and developing treatments for various medical conditions including lymphomas and immunodeficiency disorders.
Symbol: HALO
Recent Price: $47.99
Industry: Biotechnology
CEO: Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Sector: Healthcare
Employees: 373
Address: 11388 Sorrento Valley Road, San Diego, CA 92121
Phone: 858 794 8889
Last updated: 2024-12-31
Lexicon Pharmaceuticals, Inc.
Sotagliflozin, LX9211
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical products, with drugs like Sotagliflozin and LX9211 under development for heart failure, type 1 diabetes, and neuropathic pain.
About | Foundation | Leadership | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: LXRX
Recent Price: $0.72
Industry: Biotechnology
CEO: Dr. Michael Exton Ph.D.
Sector: Healthcare
Employees: 285
Address: 2445 Technology Forest Boulevard, The Woodlands, TX 77381
Phone: 281 863 3000
Leadership
- Brian Corrigan, Senior Vice President, Regulatory and Quality Assurance
- Brian Crum, Senior Vice President and General Counsel
- Lisa DeFrancesco, Vice President, Investor Relations and Corporate Communications
- Mike Exton, Ph.D., Chief Executive Officer and Director
- Tom Garner, Senior Vice President and Chief Commercial Officer
- Craig Granowitz, MD, PhD, Senior Vice President and Chief Medical Officer
- Alan Main, PhD, Executive Vice President, Innovation and Chemical Sciences
- Wendy McDermott, Senior Vice President, Human Resources
- Kristen Alexander, Vice President, Finance and Accounting
- Phillip Banks, MS, FRS, Vice President, Biostatistics and Data Management
- Kyle Burt, Vice President, Information Operations
- Amy Carroll, Ph.D., Vice President, Medical Affairs
- Melinda Francini, Vice President, Value and Access
- Desiree Gendron, Vice President, Sales and Training
- Suma Gopinathan, Ph.D., Vice President, Clinical Development
- Rachel Martens, Vice President, Partnerships and Corporate Strategy
- Nicole Moore, Vice President, Legal
- Tracy Newbold, Vice President, Clinical Operations
- Godfried Owusu-Ababio, Vice President, Technical Operations
- Rob Scala, Vice President, Business Planning and Commercial Operations
- Carrie Siragusa, Vice President, Marketing
- Dixon Terry, Vice President, Compliance
- Raymond Debbane, Chairman
- Philippe J. Amouyal,
- Samuel L. Barker, PhD,
- Robert J. Lefkowitz, MD,
- Christopher J. Sobecki,
- Diane E. Sullivan,
- Judith L. Swain, MD,
Last updated: 2024-12-31
Shuttle Pharmaceuticals Holdings, Inc.
Ropidoxuridine, Doranidazole
Shuttle Pharmaceuticals Holdings, Inc. focuses on the discovery, development, and commercialization of drugs aimed at sensitizing cancers to radiation therapy, with products such as Ropidoxuridine and Doranidazole in clinical stages.
Symbol: SHPH
Recent Price: $0.77
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. Anatoly Dritschilo M.D.
Sector: Healthcare
Employees: 8
Address: One Research Court, Rockville, MD 20850
Phone: 240 403 4212
Last updated: 2024-12-31
Reneo Pharmaceuticals, Inc.
REN001
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.
About | About | About | Management | Directors | Contact | Contact | Careers | Careers | About | About | About
Symbol: RPHM
Recent Price: $18.20
Industry: Biotechnology
CEO: Mr. Gregory J. Flesher
Sector: Healthcare
Employees: 8
Address: 18575 Jamboree Road, Irvine, CA 92612
Phone: 619 733 3852
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Travere Therapeutics, Inc.
Chenodal, Cholbam, Thiola, Sparsentan, TVT-058
Travere Therapeutics, Inc. is a biopharmaceutical company that focuses on identifying, developing, commercializing, and delivering therapies for the treatment of rare diseases. Its products include Chenodal, Cholbam, Thiola, and candidates like Sparsentan and TVT-058.
About | Leadership | About | About | About | Contact | Contact | Careers | Careers | About | News | About | About | About | About | About | About | News | Events | About | About | ESG | About | Jobs | Jobs | Careers | About | About | About | About
Symbol: TVTX
Recent Price: $17.32
Industry: Biotechnology
CEO: Dr. Eric M. Dube Ph.D.
Sector: Healthcare
Employees: 380
Address: 3611 Valley Centre Drive, San Diego, CA 92130
Phone: 888 969 7879
Leadership
- Eric Dube, Ph.D., President & Chief Executive Officer
- Chris Cline, CFA, Chief Financial Officer
- Angela Giannantonio, Senior Vice President, Human Resources
- Peter Heerma, Chief Commercial Officer
- Jula Inrig, M.D., Chief Medical Officer
- Casey Logan, Chief Business Officer
- Elizabeth Reed, J.D., Senior Vice President, General Counsel, Corporate Secretary
- William Rote, Ph.D., Senior Vice President, Research & Development
- Charlotte Smith, Senior Vice President, Public Affairs
- Gary A. Lyons, Chairman
- Roy D. Baynes, M.D., Ph.D.,
- Suzanne L. Bruhn, Ph.D.,
- Tim Coughlin, CPA,
- Jeffrey A. Meckler,
- John A. Orwin,
- Sandra E. Poole,
- Ron Squarer,
- Ruth Williams-Brinkley, FACHE,
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
Esperion Therapeutics, Inc.
NEXLETOL and NEXLIZET
Esperion Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing medicines for treating elevated low density lipoprotein cholesterol. Its main products are NEXLETOL and NEXLIZET, aimed at treating conditions like atherosclerotic cardiovascular disease.
About | Leadership | Directors | About | ESG | About | Contact | Careers | About | About | About
Symbol: ESPR
Recent Price: $2.28
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Sheldon L. Koenig
Sector: Healthcare
Employees: 240
Address: 3891 Ranchero Drive, Ann Arbor, MI 48108
Phone: 734 887 3903
Leadership
- Sheldon Koenig, Chief Executive Officer
- Glenn Brame, Chief Technical Operations Officer
- Ben Halladay, Chief Financial Officer, MBA
- Benjamin O. Looker, General Counsel
- Betty Jean (BJ) Swartz, Chief Business Officer
- Eric Warren, R.Ph., Chief Commercial Officer
- J. Martin Carroll, Chairman of the Board
- Seth H.Z. Fischer, Member of the Compliance Committee Chair of the Compensation Committee
- Alan Fuhrman, Chief Financial Officer
- Antonio Gotto, Jr., MD, DPhil, Member of the Nominating and Governance Committee
- Stephen Rocamboli, Chief Executive Officer of Innovatrx, Inc.
- Jay Shepard, Venture Partner with Catalys Pacific
- Nicole Vitullo, Lead Independent Director
- Tracy Woody, Member of the Nominating and Governance Committee Chair of the Compliance Committee
Last updated: 2024-11-08
Inozyme Pharma, Inc.
INZ-701
Inozyme Pharma, Inc. is a biopharmaceutical company focused on the development of therapeutics for rare disease conditions involving abnormal mineralization, particularly targeting ENPP1 and ABCC6 deficiencies.
Symbol: INZY
Recent Price: $2.82
Industry: Biotechnology
CEO: Dr. Douglas A. Treco Ph.D.
Sector: Healthcare
Employees: 59
Address: 321 Summer Street, Boston, MA 02210
Phone: 857 330 4340
Leadership
- Doug Treco, Ph.D., CEO, Chairman of Board of Directors
- Gayle Gironda, Senior Vice President and Chief People Officer
- Kurt Gunter, M.D., Senior Vice President and Chief Medical Officer
- Soojin Kim, Ph.D., Senior Vice President and Chief Technical Operations Officer
- Yves Sabbagh, Ph.D., Senior Vice President and Chief Scientific Officer, Chair of the Scientific Advisory Board
- Sanjay S. Subramanian, M.S., MBA, Senior Vice President and Chief Financial Officer
- Matt Winton, Ph.D., Senior Vice President and Chief Operating Officer
- Axel Bolte, MBA, Co-founder, Senior Advisor and Member of Board of Directors
- David Thompson, M.A., M.S., Ph.D., Senior Advisor, Member of Scientific Advisory Board
- Sarah Bhagat, Ph.D., Director
- Reinaldo M. Diaz, MBA, Director
- Martin Edwards M.D., MBA, Director
- Erik Harris, MBA, Director
- Rob Hopfner, Rph, Ph.D., MBA, Director
- Edward Mathers, Director
- Lynne Sullivan, MST, Director
Last updated: 2024-12-31
Lexeo Therapeutics, Inc. Common Stock
LX2006, LX2020, LX2021, LX2022, LX1001, LX1020, LX1021, LX1004
Lexeo Therapeutics is a clinical-stage genetic medicine company developing innovative gene therapy candidates targeting hereditary and acquired diseases, including cardiomyopathies and neurological conditions.
Symbol: LXEO
Recent Price: $6.54
Industry: Biotechnology
CEO: Mr. R. Nolan Townsend
Sector: Healthcare
Employees: 69
Address: 345 Park Avenue South, New York, null 10010
Phone: 212-547-9879
Last updated: 2024-12-31
Soleno Therapeutics, Inc.
Diazoxide Choline Controlled-Release
Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, including their lead candidate for Prader-Willi Syndrome.
Symbol: SLNO
Recent Price: $45.30
Industry: Biotechnology
CEO: Dr. Anish Bhatnagar M.D.
Sector: Healthcare
Employees: 33
Address: 203 Redwood Shores Parkway, Redwood City, CA 94065
Phone: 650 213 8444
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
Scilex Holding Company
ZTlido 1.8%
Scilex Holding Company is a biopharmaceutical company focused on developing and commercializing non-opioid management products for the treatment of acute and chronic pain, including its commercial product ZTlido 1.8% and several products in clinical trial stages.
About | About | About | News | News | Contact | Contact | Contact | About | About | About | About
Symbol: SCLX
Recent Price: $0.42
Industry: Drug Manufacturers - General
CEO: Mr. Jaisim Shah
Sector: Healthcare
Employees: 113
Address: 960 San Antonio Road, Palo Alto, CA 94303
Phone: 650-516-4310
Last updated: 2024-12-31
Silo Pharma, Inc.
SPC-15
Silo Pharma Inc. is a developmental stage biopharmaceutical company focusing on treatments for stress-induced psychiatric disorders, chronic pain, and CNS diseases through traditional and psychedelic therapies.
Symbol: SILO
Recent Price: $0.89
Industry: Biotechnology
CEO: Mr. Eric Weisblum
Sector: Healthcare
Employees: 3
Address: 677 N. Washington Boulevard, Sarasota, FL 34236
Phone: 718 400 9031
Last updated: 2024-12-31
Soligenix, Inc.
SGX301 (Hy Bryte), SGX942, SGX203, SGX302
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases, operating in the Specialized Bio Therapeutics and Public Health Solutions segments.
About | Directors | About | About | About | About | About | About | Contact | About | About | About | About | About | Careers | Careers | About | About | About | About | About | About | About
Symbol: SNGX
Recent Price: $2.91
Industry: Biotechnology
CEO: Dr. Christopher J. Schaber Ph.D.
Sector: Healthcare
Employees: 13
Address: 29 Emmons Drive, Princeton, NJ 08540
Phone: 609 538 8200
Leadership
- Christopher J. Schaber, PhD, Chairman, President and Chief Executive Officer
- Gregg A. Lapointe, CPA, MBA, Board Director
- Diane L. Parks, MBA, Board Director
- Robert J. Rubin, MD, Board Director
- Jerome Zeldis, MD, PhD, Board Director
Last updated: 2024-12-31
Synlogic, Inc.
Synthetic Biotic Medicines
Synlogic, Inc. is a clinical-stage biopharmaceutical company focused on the development of synthetic biotic medicines to treat metabolic and immunological diseases. The company's pipeline includes drug candidates for conditions such as phenylketonuria, homocystinuria, enteric hyperoxaluria, and solid tumors and lymphoma.
Symbol: SYBX
Recent Price: $1.40
Industry: Biotechnology
CEO: Mr. Antoine Awad
Sector: Healthcare
Employees: 6
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 401 9975
Last updated: 2024-12-31
Denali Therapeutics Inc.
BIIB122/DNL151
Denali Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing therapeutic candidates for neurodegenerative diseases. Its pipeline includes treatments for Parkinson's disease, hunter syndrome, ALS, multiple sclerosis, and Alzheimer's disease. It collaborates with companies such as Takeda Pharmaceutical Company and Genentech, Inc.
Symbol: DNLI
Recent Price: $20.24
Industry: Biotechnology
CEO: Dr. Ryan J. Watts Ph.D.
Sector: Healthcare
Employees: 364
Address: 161 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 866 8548
Last updated: 2024-12-31
Lantheus Holdings, Inc.
DEFINITY, Techne Lite, Xenon-133, Neurolite, Cardiolite, Thallium-201, Gallium-67, AZEDRA, Automated Bone Scan Index, Cobalt (Co 57), RELISTOR
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.
Symbol: LNTH
Recent Price: $89.13
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Brian A. Markison
Sector: Healthcare
Employees: 834
Address: 331 Treble Cove Road, North Billerica, MA 01862
Phone: 978 671 8001
Leadership
- Brian Markison, Chief Executive Officer
- Paul Blanchfield, President
- Jeff Humphrey, MD, Chief Medical Officer
- Robert J. Marshall Jr., Chief Financial Officer
- Amanda Morgan, Chief Commercial Officer
- Daniel Niedzwiecki, Chief Administrative Officer, General Counsel and Corporate Secretary
- Jean-Claude Provost, MD, Chief Science Officer
- Jamie Spaeth, Chief People Officer
- Cheryl Ball, Senior Vice President, Strategy and Enterprise Planning
- Dorothy Barr, Senior Vice President, Manufacturing and Technical Operations
- Kim Brown, Chief Accounting Officer
- Lee Anne Howe, Chief Information Officer
- Linda Lennox, Chief of Staff & Vice President, Corporate Communications
- Joann Nestor, Senior Vice President, Legal Affairs
- Andrea Sabens, Vice President, Business Optimization
- Carol Walker, Senior Vice President, Quality
- Mary Anne Heino, Chairperson of the Board
- Minnie Baylor-Henry, Director
- Gérard Ber, PhD, Director
- Julie Eastland, Director
- Samuel Leno, Director
- Heinz Mäusli, Director
- Julie McHugh, Director
- Gary J. Pruden, Director
- James H. Thrall, MD, Director
Last updated: 2024-12-31
Seelos Therapeutics, Inc.
SLS-002, SLS-005, SLS-006, SLS-007, SLS-008, SLS-004, SLS-010
Seelos Therapeutics, Inc. is focused on developing and commercializing therapeutics for central nervous system, respiratory, and other disorders, with lead programs targeting major depressive disorders, amyotrophic lateral sclerosis, Sanfilippo syndrome, and Parkinson's disease.
Symbol: SEEL
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Raj Mehra J.D., Ph.D.
Sector: Healthcare
Employees: 8
Address: 300 Park Avenue, New York, NY 10022
Phone: 646 293 2100
Last updated: 2024-12-31